emeis (EMEIS.PA), a healthcare provider, on Wednesday reported a narrower net loss and higher EBITDA in fiscal year 2025, benefited by revenue growth.
Looking ahead to fiscal 2026, EBITDAR growth is expected to be over 10 percent on a like-for-like or LFL basis, representing an expected average growth rate between 2024 and 2026 of over 15 percent.
Further, the firm maintained medium-term guidance, still expecting EBITDAR growth on a LFL basis of between 12 percent and 16 percent on average.
On the Paris stock exchange, shares of emeis were gaining 6.89 percent, trading at 15.05 euros.
In fiscal 2025, net loss attributable to the Group narrowed to 298 million euros from loss of 412 million euros in the previous year. Loss per share was 1.85 euros, compared to loss of 2.73 euros a year ago.
EBIT rose drastically to 173 million euros from 2 million euros in the prior year.
EBITDA grew 20 percent year-over-year to 833 million euros. EBITDA excluding IFRS 16 advanced by 135 million euros, driven by strong operational momentum as well as effective control of rental costs in 2025 compared with 2024.
EBITDAR increased 17.7 percent from last year to 872 million euros. EBITDAR margin increased to 14.8 percent in 2025 from 13.1 percent in 2024.
On LFL basis, EBITDA climbed 58 percent and EBITDAR grew 19.2 percent.
For the fiscal year 2025, revenue climbed 4.6 percent to 5.895 billion euros from 5.636 billion euros last year. Revenue climbed 6.1 percent on LFL basis, with occupancy rates rising by an average of 1.8 percentage points year-on-year to 87.6 percent.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.